Table 3.

Outcomes of BIA-ALCL in transgender patients

	Patient 1	Patient	2 Patient 3	Patient 4
Year of report	2015	2017	2018	2019
Ann-Arbor stage	Stage IE	Stage IE	Stage IE	Stage IIE
TNM stage	T4N0M0 (Stage IIA)	T4N0M0 (Stage IIA)	T4N0M0 (Stage IIA)	T4N2M0 (Stage III)
Follow-up (years)	Tumor-free at 6 months	Tumor-free at 10 months	Tumor-free at 2-year follow-up	Tumor-free at 1-year follow-up
Follow-up imaging	Post-treatment PET with no evidence of disease	Unknown	Post-treatment PET with no evidence of disease	Post-treatment PET with no evidence of disease

BIA-ALCL: breast implant-associated anaplastic large cell lymphoma; TNM: tumor extent, Lymph node status, Metastasis